Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesRebound acid hypersecretion a concern after withdrawal of PPI therapy
American Pharmacists Association, 08/04/09
A study in healthy volunteers demonstrated that after 8 weeks of therapy with a proton pump inhibitor, withdrawal resulted in significantly higher acid–related symptoms in weeks 9 to 12 compared with participants given placebo for 12 weeks.
Related Articles
Patient Satisfaction with Switching to Esomeprazole from Existing Proton Pump Inhibitor Therapy for Gastro-Oesophageal Reflux Disease: An Observational, Multicentre Study
Clinical Drug Investigation, 11/12/09
Relevance Score: 66%
Chronic Proton Pump Inhibitor Therapy Associated with Increased Development of Fundic Gland Polyps
Digestive Diseases and Sciences, 10/22/09
Relevance Score: 66%
Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment
Gastrointestinal Endoscopy, 11/20/09
Relevance Score: 65%
A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding
Clinical Therapeutics, 10/29/09
Relevance Score: 65%
Proton Pump Inhibitor Therapy Does Not Affect Hydrogen Production on Lactulose Breath Test in Subjects with IBS
Digestive Diseases and Sciences, 10/21/09
Relevance Score: 65%
Today in Stomach/GI...keeping you current
Receive free subspecialty "5-minute updates" via email
Role of free radicals in liver diseases
Hepatology International, 12/02/09
Bioequivalence of two film-coated tablets of imatinib mesylate 400 mg: A randomized, open-label, single-dose, fasting, two-period, two-sequence crossover comparison in healthy male South American volunteers
Clinical Therapeutics, 12/01/09
Optimizing the treatment of chronic viral hepatitis C
Expert Review of Gastroenterology & Hepatology, 11/30/09
Sponsor
Article Search
Sponsor